STRATEGIC PLANNING CASE STUDIES

At Trinity, we've worked on successful strategic solutions to our client's most challenging business issues.

CASE STUDY: Strategic indication prioritization

CASE STUDY: 

For this small biotech company with one product, we recommended potential adjacent indications to pursue for future licensing and acquisition opportunities.

CLIENT SITUATION:

  • Client is a small biotech company with one near-to-market product
  • Client asked Trinity to identify and prioritize indications adjacent to that of their near-to-market product as well as find potential products in those indications for future L&A activities that would be synergistic from a sales and marketing perspective
  • The goal was to create a list of 8-10 prioritized indication and products, then outline preliminary deal strategies

TRINITY'S APPROACH:

Key criteria

  • Adjacency to company’s indication of interest
  • Physician-identified unmet needs
  • Confirmation of prescriber universe overlap
  • Physician willingness to use new medications
  • Market potential
  • Current competitive landscape
  • Pipeline product commercial and acquisition potential
  • Promotional synergies
  • Value proposition to potential company targets
  • Preliminary assessment of L&A feasibility

PROJECT OUTCOMES:

Prioritized L&A targets and strategic recommendations

  • Trinity proposed a prioritized list of assets and recommendations on how to approach the potential licensing or acquisition of each asset
  • Based on the outcomes of this project, the company confirmed their strategy to focus on a single therapeutic area going forward